Codexis Weighs ECO Scale As Cash Runway Tightens (NASDAQ:CDXS)

Core Insights - Codexis (NASDAQ: CDXS) is transitioning from selling enzyme parts to becoming an integrated supplier of siRNA through their ECO synthesis technology, which aims to enhance the efficiency of pharmaceutical research and production [1] Group 1: Company Overview - Codexis specializes in enzymatic solutions that improve pharmaceutical research and production efficiency [1] Group 2: Technological Development - The company is evolving its business model to include integrated siRNA supply alongside its existing enzyme offerings, leveraging its ECO synthesis technology [1]